{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-039020","form_type":"8-K","ticker":"XAIR","cik":"0001641631","company_name":"Beyond Air, Inc.","filed_at":"2026-08-18T20:30:32+00:00","discovered_at":"2026-08-18T20:32:12.595375+00:00","generated_at":"2026-08-18T20:32:25.268544+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Beyond Air Q1 revenue $1.8M flat YoY, net loss $7.9M; raises $30.1M financing, reaffirms CY2026 guidance","bullets":["Revenue $1.8M flat YoY; gross margin improved to 13% from 9%.","Net loss $7.9M ($11.00/share) vs $7.7M ($30.67/share) prior year.","Cash $15.2M at June 30; subsequent up to $30.1M financing ($10.2M upfront, $20M warrants, $10M tied to FDA approval).","Reaffirms CY2026 revenue guidance $8M; CY2027 $16-18M (110%+ growth).","PMA supplement for 2nd-gen LungFit PH under FDA review; approval expected 2H CY2026; GPO deal adds ~2,000 hospitals."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-039020","json":"https://secwatch.observer/filing/0001493152-26-039020.json","markdown":"https://secwatch.observer/filing/0001493152-26-039020.md","text":"https://secwatch.observer/filing/0001493152-26-039020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641631/000149315226039020/0001493152-26-039020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641631/000149315226039020/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-18T20:32:25.268544+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}